EGFR Exon 19 Deletion Subtypes and Osimertinib Treatment Response in Chinese NSCLC Cohort

This dataset contains the variant and clinical data supporting the findings of the manuscript "Sensitivity of different epidermal growth factor receptor (EGFR) exon 19 deletion subtypes to first-line osimertinib in Chinese non-small cell lung cancer patients" (currently under review at BMC Cancer).This dataset is instrumental for oncologists, cancer researchers, and bioinformaticians interested in the precision oncology of lung cancer. It allows for the independent verification of our study's conclusions and facilitates the exploration of the functional and clinical impacts of specific EGFR deletion variants.